Cargando…

Abstracts from the First European Meeting for ATTR Amyloidosis for Doctors and Patients: Paris, France. 02-03 November 2017

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Meeting Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5688433/ http://dx.doi.org/10.1186/s13023-017-0710-5

Ejemplares similares

Diagnosis and Treatment of AL and ATTR Amyloidosis
por: Faiman, Beth, et al.
Publicado: (2021)

Sepsis 2017 Paris: Paris, France. September 11–13, 2017
Publicado: (2017)

Quality of life in ATTR amyloidosis
por: Lane, Thirusha, et al.
Publicado: (2015)

Abstracts from the NIHR INVOLVE Conference 2017: London, UK. 28 November 2017
por: Muir, Delia, et al.
Publicado: (2017)

Guidelines for genetic counselling in ATTR amyloidosis
por: Sequeiros, Jorge
Publicado: (2015)

Heart transplantation in hereditary ATTR amyloidosis
por: Slama, M
Publicado: (2015)

Sepsis 2016 Paris: Paris, France. 6-8 December 2016
por: Ingles, Marcia, et al.
Publicado: (2016)

Immunotherapy Bridge 2017 and Melanoma Bridge 2017: meeting abstracts
por: Carbone, David, et al.
Publicado: (2018)

Geometric science of information: third international conference, GSI 2017, Paris, France, November 7-9, 2017, proceedings
por: Nielsen, Frank, et al.
Publicado: (2017)

Abstracts from The College of Podiatry Annual Conference 2017: Liverpool, United Kingdom. 16-18 November 2017
Publicado: (2018)

Meeting abstracts from the 11th European Cytogenetics Conference: late breaking abstracts: Florence, Italy. July 01-04, 2017
Publicado: (2017)

ATTR Amyloidosis: development of cardiac symptoms during 6 years of follow up in different ATTR-variants
por: Klaassen, Sebastiaan, et al.
Publicado: (2015)

Glavonoid, a possible supplement for prevention of ATTR amyloidosis
por: Matsushita, Hiroaki, et al.
Publicado: (2021)

Quality of life assessment in amyloid transthyretin (ATTR) amyloidosis
por: Aimo, Alberto, et al.
Publicado: (2021)

Conventional heart failure therapy in cardiac ATTR amyloidosis
por: Ioannou, Adam, et al.
Publicado: (2023)

Meeting abstracts from the 11th European Cytogenetics Conference: Florence, Italy. 01–04 July 2017
Publicado: (2017)

Cardiac amyloidosis: diagnostic challenges and recent advancement in the treatment of transthyretin amyloidosis (ATTR)
por: Rahman, Tanvir, et al.
Publicado: (2021)

A Brief Journey through Protein Misfolding in Transthyretin Amyloidosis (ATTR Amyloidosis)
por: Gonzalez-Duarte, Alejandra, et al.
Publicado: (2021)

Abstracts from the International Society for Therapeutic Ultrasound Conference 2017: Nanjing, China. 31 May - 02 June 2017
Publicado: (2018)

British Society of Breast Radiology Annual Scientific Meeting 2017: Dublin, Ireland. 5-7 November 2017
Publicado: (2017)

2017 ASCB Annual Meeting Abstracts
Publicado: (2017)

PW03-029 – Risk factors for AA-type amyloidosis in Germany
por: Blank, N, et al.
Publicado: (2013)

BACR/BIR/RSM joint winter meeting 28-30 November, 1988. Abstract of the proceedings
Publicado: (1989)

A Descriptive Analysis of ATTR Amyloidosis in Spain from the Transthyretin Amyloidosis Outcomes Survey
por: González-Moreno, Juan, et al.
Publicado: (2021)

The landscape of treatment of chronic kidney disease in hereditary ATTR amyloidosis
por: Lobato, Luisa
Publicado: (2015)

TUDCA as an autophagic modulator of ATTR V30M Amyloidosis
por: Teixeira, Cristina, et al.
Publicado: (2015)

The role of complement in ATTR amyloidosis: a new therapeutic avenue?
por: Panayiotou, Elena, et al.
Publicado: (2015)

Symptomatic therapy in ATTR amyloidosis: pain killers in TTR-FAP
por: Attal, Nadine
Publicado: (2015)

Hereditary ATTR Amyloidosis in Austria: Prevalence and Epidemiological Hot Spots
por: Auer-Grumbach, Michaela, et al.
Publicado: (2020)

Expert consensus recommendations to improve diagnosis of ATTR amyloidosis with polyneuropathy
por: Adams, David, et al.
Publicado: (2020)

Practice of Hereditary ATTR Amyloidosis in Non-endemic Areas of Japan
por: Matsushima, Masaaki, et al.
Publicado: (2022)

Selected Abstracts from the 3rd European Hereditary Tumour Group Meeting (EHTG 2018): Nice, France. 23-25 September 2018
Publicado: (2019)

P02-019 - Detection of risk factors for AA-amyloidosis
por: Németh, S, et al.
Publicado: (2013)

Abstracts of the 27th Congress of the World Society of Cardiovascular and Thoracic Surgeons (WSCTS): Astana, Kazakhstan. 01-03 September 2017
Publicado: (2017)

Patient and family experience with transthyretin amyloid cardiomyopathy (ATTR-CM) and polyneuropathy (ATTR-PN) amyloidosis: results of two focus groups
por: Rintell, David, et al.
Publicado: (2021)

ESICM LIVES 2018: Paris, France. 20-24 October 2018
Publicado: (2018)

Do we need to demonstrate amyloid in tissue for hereditary ATTR amyloidosis ?
por: Westermark, Per
Publicado: (2015)

Unusual case of ATTR amyloidosis with cardiac manifestation and situs inversus totalis
por: Fritschka, Max, et al.
Publicado: (2017)

Genetic background modifies amyloidosis in a mouse model of ATTR neuropathy
por: Panayiotou, E., et al.
Publicado: (2016)

Tafamidis for autonomic neuropathy in hereditary transthyretin (ATTR) amyloidosis: a review
por: Cruz, Márcia Waddington
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ccu08s5hpk89p914peei45je7m